CCL2 and breast carcinoma: Additionally, they showed that this HS mimetic, potentially by binding to CCL2, inhibits breast cancer CCL2-mediated cell proliferation and CCR2/CCL2- mediated cell migration, and it reduces cell invasiveness (130).